| 20.11.2024 12:05 | PRTC | PRTC's Seaport Adds Microsoft and J&J Exec to BOD | Reach |
| 05.11.2024 12:05 | PRTC | PRTC's Seaport Adds Biotech Finance Exec as CFO | Reach |
| 01.11.2024 07:00 | PRTC | Total Voting Rights | RNS |
| 31.10.2024 17:00 | PRTC | Director/PDMR Shareholding | RNS |
| 30.10.2024 11:00 | PRTC | PRTC to Present at UBS and Jefferies Conferences | Reach |
| 21.10.2024 07:00 | PRTC | PRTC's Seaport Closes $225M Series B Financing | RNS |
| 09.10.2024 10:03 | PRTC | PureTech Health investigates IPF disease burden amid treatment testing | Alliance |
| 09.10.2024 07:00 | PRTC | PRTC's IPF Patient Research & Ph 2b On Track YE24 | Reach |
| 01.10.2024 12:00 | PRTC | PRTC to Give 3 Presentations at CHEST 2024 Meeting | Reach |
| 27.09.2024 11:30 | PRTC | PureTech Health celebrates KarXT approval by FDA for schizophrenia | Alliance |
| 27.09.2024 07:00 | PRTC | KarXT/Cobenfy Approved by FDA; PRTC Receives $29M | RNS |
| 06.09.2024 18:13 | PRTC | Holding(s) in Company | RNS |
| 06.09.2024 18:07 | PRTC | IN BRIEF: PureTech's Vor in promising findings in cancer trial | Alliance |
| 06.09.2024 07:00 | PRTC | PRTC's Vor Shares New AML Data Validating Approach | Reach |
| 29.08.2024 14:51 | PRTC | CORRECT (Aug 28): PureTech Health loss widens and revenue falls | Alliance |
| 28.08.2024 09:28 | PRTC | PureTech Health loss widens and revenue falls amid AGM concerns | Alliance |
| 28.08.2024 07:01 | PRTC | Half-year Report | RNS |
| 28.08.2024 07:00 | PRTC | Results of AGM on 13 June 2024 – Update Statement | RNS |
| 22.08.2024 07:00 | PRTC | PRTC Adds Industry Leader to Board of Directors | RNS |
| 21.08.2024 14:20 | PRTC, PRU, PBEE | UK earnings, trading statements calendar - next 7 days | Alliance |
| 21.08.2024 07:00 | PRTC | Notice of Results | RNS |
| 19.08.2024 14:20 | PRTC | UK earnings, trading statements calendar - next 7 days | Alliance |
| 13.08.2024 12:05 | PRTC | PRTC's Seaport Appoints Global Pharma Exec to BOD | Reach |
| 23.07.2024 12:05 | PRTC | PRTC'S Vedanta Expands Leadership Team | Reach |
| 01.07.2024 17:00 | PRTC | Holding(s) in Company | RNS |
| 27.06.2024 17:01 | PRTC | PDMR Notification RSU Vesting | RNS |
| 27.06.2024 17:00 | PRTC | Director/PDMR Shareholding | RNS |
| 24.06.2024 19:46 | NWG, JLP, CCR | EARNINGS AND TRADING: PureTech seals tender offer; HL bid questioned | Alliance |
| 24.06.2024 17:00 | PRTC | Completion of Tender Offer & Total Voting Rights | RNS |
| 24.06.2024 07:00 | PRTC | Result of Tender Offer | RNS |
| 20.06.2024 07:00 | PRTC | Director Declaration | RNS |
| 18.06.2024 12:05 | PRTC | PRTC's Seaport Appoints Seasoned Execs to Team | Reach |
| 13.06.2024 17:42 | PRTC | Result of AGM | RNS |
| 07.06.2024 17:30 | PRTC | Holding(s) in Company | RNS |
| 06.06.2024 17:34 | PRTC | Result of Meeting | RNS |
| 04.06.2024 07:00 | PRTC | Additional Disclosure Re: Tender Offer | RNS |
| 03.06.2024 07:00 | PRTC | Total Voting Rights | RNS |
| 29.05.2024 21:30 | PRTC | IN BRIEF: PureTech's Ankili to be acquired by Virtual Therapeutics | Alliance |
| 29.05.2024 13:04 | PRTC | PRTC's Akili Enters Into Merger Agreement | RNS |
| 23.05.2024 12:00 | PRTC | PRTC to Present at Jefferies Healthcare Conference | Reach |
| 21.05.2024 14:07 | PRTC | PureTech-founded Vedanta begins trials for VE303 colonic bacteria drug | Alliance |
| 21.05.2024 12:05 | PRTC | PRTC's Vedanta Begins Phase 3 of VE303 in C. diff | Reach |
| 20.05.2024 09:03 | PRTC | IN BRIEF: PureTech Health launches USD100 million buyback programme | Alliance |
| 20.05.2024 07:00 | PRTC | Tender Offer | RNS |
| 10.05.2024 16:39 | CTAI, AMAT, PRTC | EARNINGS AND TRADING: Asiamet Resources declares special dividend | Alliance |
| 10.05.2024 16:39 | CTAI, AMAT, PRTC | EARNINGS AND TRADING: Asiamet Resources declares special dividend | Alliance |
| 09.05.2024 12:05 | PRTC | PRTC's Seaport Presents Ph1 and Ph2a SPT-300 Data | Reach |
| 07.05.2024 12:05 | PRTC | PRTC's Seaport Announces Board/Team Appointments | Reach |
| 01.05.2024 07:00 | PRTC | Total Voting Rights | RNS |
| 25.04.2024 09:59 | PRTC | PureTech touts "momentum" as grants shrivel but annual loss narrows | Alliance |
| 25.04.2024 07:00 | PRTC | Final Results | RNS |
| 18.04.2024 14:17 | WPP, SMWH, ZIN | UK earnings, trading statements calendar - next 7 days | Alliance |
| 18.04.2024 07:00 | PRTC | Notice of Results | RNS |
| 16.04.2024 21:57 | GMET, DOM, DPP | EARNINGS AND TRADING: J Smart boosts revenue, Tertiary starts drilling | Alliance |
| 16.04.2024 12:00 | PRTC | PRTC LYT-100 Ph2b in IPF Enrolled; Results Q4 2024 | Reach |
| 11.04.2024 13:01 | PRTC | US FDA hands fast track to PureTech head and neck cancer treatment | Alliance |
| 11.04.2024 12:00 | PRTC | FDA Grants PRTC's LYT-200 Fast Track Designation | Reach |
| 09.04.2024 11:33 | PRTC | PureTech Health CEO Zohar moves to head-up portfolio firm Seaport | Alliance |
| 09.04.2024 07:00 | PRTC | PRTC Launches Seaport w/ $100M; Leadership Changes | RNS |
| 19.03.2024 11:16 | PRTC | PureTech shares jump on USD100 million tender offer proposal | Alliance |
| 19.03.2024 07:00 | PRTC | $100M Tender Offer | RNS |
| 18.03.2024 13:32 | PRTC | $14B Acquisition of PRTC’s Karuna by BMS Completed | RNS |
| 13.03.2024 12:27 | PRTC | PureTech Health celebrates drug designation for LYT-200 from US FDA | Alliance |
| 13.03.2024 11:00 | PRTC | FDA Grants PRTC's LYT-200 Orphan Drug Designation | Reach |
| 06.03.2024 07:00 | PRTC | PDMR Notification RSU Vesting | RNS |
| 27.02.2024 12:00 | PRTC | PRTC to Present at Cowen and Leerink Conferences | Reach |
| 27.02.2024 11:28 | PRTC | PureTech notes positive results from Shionogi's EndeavorRx ADHD trial | Alliance |
| 27.02.2024 07:00 | PRTC | PRTC: Akili Positive Ph3 & Japan PMDA Submission | Reach |
| 08.02.2024 07:00 | PRTC | Transaction in Own Shares | RNS |
| 07.02.2024 07:00 | PRTC | Transaction in Own Shares | RNS |
| 05.02.2024 07:00 | PRTC | Transaction in Own Shares | RNS |
| 31.01.2024 07:00 | PRTC | Transaction in Own Shares | RNS |
| 30.01.2024 07:00 | PRTC | Transaction in Own Shares | RNS |
| 29.01.2024 17:30 | PRTC | Transaction in Own Shares | RNS |
| 26.01.2024 07:00 | PRTC | Transaction in Own Shares | RNS |
